Live interview with Dr. Michael Haller, TrialNet

TrialNet is an international clinical trials network of the world’s leading researchers who are exploring ways to prevent, delay and reverse progression of type 1 diabetes. The network consists of leading academic institutions, physicians, and research teams at the forefront of type 1 diabetes research.